T. Rowe Price Associates’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-21
| Closed | -$21K | – | 3030 |
|
|
2021
Q4 | $21K | Hold |
21
| – | – | ﹤0.01% | 2956 |
|
|
2021
Q3 | $41K | Sell |
21
-20
| -49% | -$39K | ﹤0.01% | 2904 |
|
|
2021
Q2 | $110K | Sell |
41
-3
| -7% | -$8.05K | ﹤0.01% | 2829 |
|
|
2021
Q1 | $182K | Buy |
44
+21
| +91% | +$86.9K | ﹤0.01% | 2709 |
|
|
2020
Q4 | $131K | Buy |
23
+16
| +229% | +$91.1K | ﹤0.01% | 2605 |
|
|
2020
Q3 | $40K | Buy |
+7
| New | +$40K | ﹤0.01% | 2552 |
|
|
2017
Q1 | – | Sell |
-14
| Closed | -$158K | – | 2601 |
|
|
2016
Q4 | $158K | Hold |
14
| – | – | ﹤0.01% | 2418 |
|
|
2016
Q3 | $194K | Sell |
14
-7
| -33% | -$97K | ﹤0.01% | 2358 |
|
|
2016
Q2 | $313K | Buy |
+21
| New | +$313K | ﹤0.01% | 2149 |
|